Effects of radiofrequency electromagnetic fields (RF EMF) on cancer in laboratory animal studies

Mevissen, Meike; Ward, Jerrold M.; Kopp-Schneider, Annette; MacNamee, James P.; Wood, Andrew W.; Rivero, Tania M.; Thayer, Kristina; Straif, Kurt (2022). Effects of radiofrequency electromagnetic fields (RF EMF) on cancer in laboratory animal studies. Environment International, 161, p. 107106. Elsevier 10.1016/j.envint.2022.107106

[img]
Preview
Text
Mevissen_et_al_2022_Protocol_of_systematic_review.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (528kB) | Preview

Background: The carcinogenicity of radiofrequency electromagnetic fields (RF EMF) has been evaluated by the International Agency for Research on Cancer (IARC) in 2011. Based on limited evidence of carcinogenicity in humans and in animals, RF EMF were classified as possibly carcinogenic to humans (Group 2B). In 2018, based on a survey amongst RF experts, WHO prioritized six major topics of potential RF EMF related human health effects for systematic reviews. In the current manuscript, we present the protocol for the systematic review of experimental laboratory animal studies (cancer bioassays) on exposure to RF fields on the outcome of cancer in laboratory animals.

Objective: In the framework of WHO's Radiation Program, the aim of this work is to systematically evaluate effects of RF EMF exposure on cancer in laboratory animals.

Study eligibility and criteria: WHO's Handbook (2014) for guideline development will be followed with appropriate adaptation. The selection of eligible studies will be based on Population, Exposures, Comparators, and Outcomes (PECO) criteria. We will include peer-reviewed articles and publicly available reports from government agencies reporting original data about animal cancer bioassays on exposure to RF EMF. The studies are identified by searching the following databases: MEDLINE (PubMed), Science Citation Index Expanded and Emerging Sources Citation Indes (Web of Science), Scopus, and the EMF Portal. No language or year-of-publication restrictions are applied. The methods and results of eligible studies will be presented in accordance with the PRISMA 2020 guidelines.

Study appraisal method: Study evaluation of individual studies will be assessed using a risk of bias (RoB) tool developed by the Office of Health Assessment and Translation (OHAT) with appropriate considerations including sensitivity for evaluating RF EMF exposure in animal cancer bioassays. The final evaluation on the certainty of the evidence on a carcinogenic risk of RF EMF exposure in experimental animals will be performed using the OHAT Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach with appropriate considerations. The protocol has been registered in an open-source repository (PROSPERO).

Item Type:

Journal Article (Original Article)

Division/Institute:

13 Central Units > Administrative Director's Office > University Library of Bern
05 Veterinary Medicine > Department of Clinical Research and Veterinary Public Health (DCR-VPH) > Veterinary Pharmacology and Toxicology

UniBE Contributor:

Mevissen, Meike, Rivero, Tania Mercedes

Subjects:

000 Computer science, knowledge & systems > 020 Library & information sciences
500 Science > 570 Life sciences; biology

ISSN:

0160-4120

Publisher:

Elsevier

Funders:

[93] World Health Organization

Language:

English

Submitter:

Angélique Ducray

Date Deposited:

02 Feb 2023 09:50

Last Modified:

05 Feb 2023 02:26

Publisher DOI:

10.1016/j.envint.2022.107106

PubMed ID:

35091376

Uncontrolled Keywords:

Animal studies; Bioassay; Carcinogenesis, toxicity, systematic review; Carcinogenicity; Radiofrequency electromagnetic fields; Radiofreuency exposure

BORIS DOI:

10.48350/178196

URI:

https://boris.unibe.ch/id/eprint/178196

Actions (login required)

Edit item Edit item
Provide Feedback